Achieve Life Sciences (ACHV) Reports In-Line Q4 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Stifel Previews Levi Strauss & Co. (LEVI) Earnings: 'Expecting Upside Passed Through to FY26E Guidance'
• Culp, Inc. (CULP) Misses Q4 EPS by 12c
• Tyson (TSN) PT Lowered to $63 at Bernstein SocGen Group Ahead of Earnings